Johnson & Johnson Available-for-sale Securities, Equity Securities
Johnson & Johnson (JNJ) had Available-for-sale Securities, Equity Securities of $697.00 million as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesEquitySecurities · last filed 2018-10-31
- 2018-09-30: Available-for-sale Securities, Equity Securities $697.00M.
- 2018-07-01: Available-for-sale Securities, Equity Securities $697.00M.
- 2018-04-01: Available-for-sale Securities, Equity Securities $731.00M.
- 2017-12-31: Available-for-sale Securities, Equity Securities $751.00M.
| Period end | Available-for-sale Securities, Equity Securities |
|---|---|
| 2018-09-30 | $697.00M 10-Q · filed 2018-10-31 |
| 2018-07-01 | $697.00M 10-Q · filed 2018-08-02 |
| 2018-04-01 | $731.00M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $751.00M 10-Q · filed 2018-10-31 |
| 2017-10-01 | $920.00M 10-Q · filed 2017-11-02 |
| 2017-07-02 | $1.04B 10-Q · filed 2017-08-03 |
| 2017-04-02 | $1.01B 10-Q · filed 2017-05-08 |
| 2017-01-01 | $1.21B 10-Q · filed 2017-11-02 |
| 2016-10-02 | $1.33B 10-Q · filed 2016-11-04 |
| 2016-07-03 | $1.28B 10-Q · filed 2016-08-04 |
| 2016-01-03 | $1.49B 10-Q · filed 2016-11-04 |
| 2015-03-29 | $314.00M 10-Q · filed 2015-05-01 |
| 2014-12-28 | $284.00M 10-Q · filed 2015-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |